首页> 外文OA文献 >Liver Transplantation for Alcoholic Liver Disease in Europe: A Study from the ELTR (European Liver Transplant Registry)
【2h】

Liver Transplantation for Alcoholic Liver Disease in Europe: A Study from the ELTR (European Liver Transplant Registry)

机译:欧洲酒精性肝病的肝移植:来自ELTR(欧洲肝移植注册机构)的研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Alcohol-related liver disease (ALD) is one of the most common indications for liver transplantation (LT). Long-term outcome after LT for ALD versus other etiologies is still under debate. The aim of this study was to compare outcome after LT of patients with ALD, viral (VIR), and cryptogenic cirrhosis. Donor, graft and recipient ELTR variables were analysed in transplants for alcoholic and nonalcoholic cirrhosis (1988-2005) and were correlated with patient survival. Causes of death and/or graft failure were compared between groups. Nine thousand eight hundred eighty ALD, 10,943 VIR, 1478 ALD+VIR and 2410 cryptogenic (CRYP) liver transplants were evaluated. One, 3, 5 and 10 years graft survival rates after LT in ALD patients were 84%, 78%, 73%, 58%, significantly higher than in VIR and CRYP (p=0.04, p=0.05). By multivariate analysis, ALD+VIR (RR 1.14) and viral alone (RR 1.06) were significant risk factors for mortality. De novo tumors, cardiovascular and social causes were causes of death/graft failure in higher percentage in ALD groups versus other etiologies. LT for ALD cirrhosis has a favorable outcome, however, hepatitis C virus co-infection seems to eliminate this advantage. Screening for de novo tumors and prevention of cardiovascular complications are essential to provide better long-term results.
机译:酒精相关性肝病(ALD)是肝移植(LT)的最常见适应症之一。长期使用ALD与其他病因后的长期结果仍存在争议。这项研究的目的是比较ALD,病毒性(VIR)和隐源性肝硬化患者LT的结局。在酒精和非酒精性肝硬化的移植物中分析了供体,移植物和受体ELTR变量(1988-2005年),并与患者生存率相关。比较两组之间的死亡原因和/或移植失败。评估了988例ALD,10,943例VIR,1478例ALD + VIR和2410隐源性(CRYP)肝移植。 ALD患者LT后1、3、5和10年的移植物存活率分别为84%,78%,73%,58%,显着高于VIR和CRYP(p = 0.04,p = 0.05)。通过多变量分析,ALD + VIR(RR 1.14)和仅病毒(RR 1.06)是导致死亡的重要危险因素。与其他病因相比,ALD组的新生肿瘤,心血管和社会原因是死亡/移植失败的原因。 LT对于ALD肝硬化具有良好的疗效,但是,丙型肝炎病毒共感染似乎消除了这一优势。从头筛查肿瘤和预防心血管并发症对于提供更好的长期结果至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号